Parallel Advisors, LLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in AUPH

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$10,572

+$1,769 QoQ

Shares Held

623

+4.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#244

of 279 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. AUPH ranks #76 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	3,962,177	$344,511,290
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,389	$2,676,877
3	RCUS	Arcus Biosciences, Inc.	86,557	$2,668,552
4	REGN	Regeneron Pharmaceuticals, Inc.	1,063	$662,823
5	KRYS	Krystal Biotech, Inc.	1,699	$631,467
6	ARGX	Argenx SE	640	$593,772
7	INCY	Incyte Corp	4,961	$562,378
8	VKTX	Viking Therapeutics, Inc.	13,833	$539,625

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,572	623	+4.9%	Shares	Sole	2026-08-05
2026-03-31	$8,803	594	0.0%	Shares	Sole	2026-05-07
2025-12-31	$9,474	594	0.0%	Shares	Sole	2026-02-11
2025-09-30	$6,563	594	+1281.4%	Shares	Sole	2025-11-13
2025-03-31	$345	43	0.0%	Shares	Sole	2025-04-08
2024-12-31	$386	43	+258.3%	Shares	Sole	2025-02-10
2023-12-31	$107	12	-99.4%	Shares	Sole	2024-02-12
2021-03-31	$27,917	2,150	-48.2%	Shares	Sole	2021-04-23
2020-12-31	$57,394	4,150	+5828.6%	Shares	Sole	2021-02-02
2020-09-30	$1,031	70	—	Shares	Sole	2020-10-27
No filing history on record for this holder in this stock.